RESEARCH INFORMATICS: Optimizing and Integrating Informatics for Drug Development
	Cambridge Healthtech Institute , Philadelphia, Pennsylvania November 29-30, 2000
	The explosion of genomic information, from sequences and gene expression to SNPs and protein structures, is of limited value for pharmaceutical researchers without powerful software capable of interpretation and comparisons. Similarly, the potential value of combinatorial libraries, the results of high-throughput screening and structure-based drug design, also depend heavily on computation insight and analysis. While it is a significant challenge to develop improved bioinformatics or chemoinformatics that serve the needs of all of the researchers involved with a given project, there is an even greater challenge in finding ways that these two disciplines can be integrated. Such integration, however, holds great promise for producing much of the needed and anticipated advances in efficiency sought by the pharmaceutical industry. Case studies and experience that companies have with both the problems and solutions in the areas of data mining, multiple location data sharing, computational enhancements of biological and chemistry projects, as well as integration of these efforts, will serve as the focus of this meeting. Different approaches for overcoming the problems of legacy information systems, the very different language and perspectives of chemists and biologists, and the organizational issues of compartmentalization, will be among the key topics to be discussed.
	Organized by:	Cambridge Healthtech Institute
	Invited Speakers:	Adam Sartiel, M.Sc., MBA Manager, International Marketing and Business Development, LabOnWeb.com David A. Nielsen, Ph.D., Senior Bioinformatics Specialist, InforMax, Inc.
	Deadline for Abstracts:	November 3, 2000
	Registration:	Available on-line
	Email for Requests and Registration:	jlaakso@healthtech.com
	Posted by: Jennifer Laakso   Host: wks217.healthtech.com date: June 29, 2000 19:55:55 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.